Anti-phospholipase C antibodies inhibit the lectin-induced proliferation of human lymphocytes

Biosci Rep. 1987 Sep;7(9):731-6. doi: 10.1007/BF01116866.

Abstract

A novel approach was used to assess the role of phosphoinositide hydrolysis in the mitogenic action of phytohemagglutinin (PHA) or concanavalin A (ConA). The treatment of human peripheral blood leukocytes (PBL) with monospecific antibodies against phospholipase C (PLC) produced a dose-dependent inhibition (up to 100%) of PHA (10 micrograms/ml) or ConA (25 micrograms/ml) proliferative effects. Thus, the activation of membrane-bound PLC is a sine-qua-non condition for lectin-induced proliferation of T lymphocytes. The key-role of PLC versus protein kinase C (PKC) is stressed by the fact that the inhibition of PKC with Hidaka's compound H-7 (40 microM) produced only a partial blockade (about 25%) of lectin mitogenic effect.

MeSH terms

  • Antibodies / immunology*
  • Dose-Response Relationship, Immunologic
  • Humans
  • Immunoglobulin Fragments / immunology
  • Lectins / pharmacology
  • Lymphocyte Activation*
  • Type C Phospholipases / immunology
  • Type C Phospholipases / metabolism*

Substances

  • Antibodies
  • Immunoglobulin Fragments
  • Lectins
  • Type C Phospholipases